Skip to main content
Equibles

Squarepoint Ops LLC

Position in MRK — Merck & Co., Inc.

CIK 1642575 NEW YORK, NY
Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$116,893,366
+$16,949,578 QoQ
Shares Held
909,676
+9.5% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#195
of 3,766 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2026
CallValue
$10,806,850
CallShares
84,100
PutValue
$6,270,800
PutShares
48,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,171,914,058 across 14 Drug Manufacturers - General names. MRK ranks #4 (10.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 1,247,079 $316,720,653
2 LLY
ELI LILLY & Co
 245,569 $294,542,850
3 GILD
Gilead Sciences, Inc.
 1,823,224 $230,346,120
4 MRK
Merck & Co., Inc.
This page 		909,676 $116,893,366
5 PFE
Pfizer Inc
 3,310,002 $79,704,848
6 AMGN
Amgen Inc
 208,010 $75,324,581
7 ABBV
AbbVie Inc.
 91,950 $23,138,298
8 BMY
Bristol Myers Squibb Co
 324,626 $18,704,950

All Filings in MRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,806,850 84,100
2026-06-30 $116,893,366 909,676
2026-06-30 $6,270,800 48,800
2026-03-31 $14,302,481 118,900
2026-03-31 $58,448,911 485,900
2026-03-31 $99,943,788 830,857
2025-12-31 $14,136,418 134,300
2025-12-31 $6,962,422 66,145
2025-12-31 $57,103,550 542,500
2025-09-30 $95,266,257 1,135,068
2025-09-30 $28,712,453 342,100
2025-09-30 $35,326,137 420,900
2025-06-30 $57,588,900 727,500
2025-06-30 $82,587,628 1,043,300
2025-06-30 $245,600,391 3,102,582
2025-03-31 $347,903,835 3,875,934
2025-03-31 $87,336,480 973,000
2025-03-31 $56,180,784 625,900
2024-12-31 $182,952,971 1,839,093
2024-12-31 $15,230,388 153,100
2024-12-31 $30,192,180 303,500
2024-09-30 $26,845,584 236,400
2024-09-30 $16,307,216 143,600
2024-09-30 $172,387,486 1,518,030
2024-06-30 $107,696,219 869,921
2024-06-30 $17,567,220 141,900
2024-06-30 $10,337,300 83,500
2024-03-31 $122,093,335 925,300
2024-03-31 $57,919,452 438,950
2024-03-31 $22,114,820 167,600
2023-12-31 $12,155,730 111,500
2023-12-31 $11,774,160 108,000
2023-12-31 $152,160,413 1,395,711
2023-09-30 $17,213,240 167,200
2023-09-30 $96,094,662 933,411
2023-09-30 $16,019,020 155,600
2023-06-30 $24,598,609 213,178
2023-06-30 $5,538,720 48,000
2023-06-30 $6,127,209 53,100
2023-03-31 $234,058 2,200
2023-03-31 $2,022,154 19,007
2022-12-31 $3,916,535 35,300
2022-12-31 $9,595,621 86,486
2022-12-31 $6,191,010 55,800
2022-09-30 $5,589,188 64,900
2022-09-30 $4,486,852 52,100
2022-09-30 $9,606,513 111,548
2022-06-30 $10,231,644 112,226
2022-06-30 $18,370,755 201,500
2022-06-30 $15,243,624 167,200

Report a Problem

Category
Description
Email (optional, for follow-up)